STENTiT: Scaffolds Regenerate Arteries From the Inside Out

article image

While the first generation of bioresorbable stents aims to enhance the treatment of peripheral artery disease with temporary support, STENTiT is on to the next generation with a platform of resorbable devices that promise to do what no stent can: elicit natural regeneration of the artery.

In theory, bioresorbable polymer stents make much more sense than permanent metal stents. After an endovascular procedure on an occluded artery a resorbable stent supports the vessel for a time by preventing acute elastic recoil, restenosis, and late negative remodeling (i.e., vessel narrowing caused by fibrosis), then it goes away. As a result, no inflammatory materials remain in the body to cause trouble and interfere with vessel patency. Metal stents, as permanent implants, sometimes require long-term antiplatelet therapy to manage the risk of thrombosis, and in caging the vessel, they might preclude future surgical treatment options.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: